News
Our passion for innovation and improvement keeps us in constant motion, and we want to share the latest updates and news with you.
Live with four pilot projects in Germany
Together with our partner mediq Innovation Experts in Germany, Vitalthings has integrated Vitalthings Guardian M10 into leading German clinics to analyse workflows and generate early evidence of cost-benefit.
Strategic collaboration between Atea and Vitalthings
Health technology company Vitalthings and IT company Atea have entered into a strategic partnership to strengthen the municipal health service with new technology that frees up time and improves patient follow-up. "Our goal is to double the municipalities' health and care capacity. With this agreement, we are one step closer to achieving that goal," says Endre Valdersnes, Director of eHealth and Welfare Technology at Atea.
Vitalthings Guardian M10 in operation at St. Olav's Hospital
In October, 44 units of our contactless, proactive patient monitor Guardian M10 were put into use at St. Olavs Hospital. This brings the groundbreaking patient monitor that continuously measures respiratory rate into operation in three departments: the emergency department, orthopedics and pulmonary.
Appearances
Here is an overview of where you can meet us. We participate in a variety of conferences and events, both domestically and internationally. See you there!
Blog
"Improving people’s lives" is an important part of our identity. Through the blog, we showcase how our technology can indeed contribute to improving people's lives.
Falls in the Elderly
How to prevent?
How to prevent falls? In Norway, approximately 9000 adults suffer hip fractures each year. Read how Dr. Remi Andersen from Ullernhjemmet...
Blå Kors adopts Somnofy for Isolation Rooms
Blå Kors Lade Treatment Center in Trondheim has now installed Somnofy in all its rooms in the detoxification unit. They have...
WEBINAR
We are Here to Assist you
Soon, you'll find our educational and informative webinars here. Stay tuned, and feel free to subscribe to our newsletter for the latest updates.
EN 
NO